Literature DB >> 15034276

Glycobiology of the neuromuscular junction.

Paul T Martin1.   

Abstract

Most molecules that are present at synapses are glycosylated with carbohydrates, and some carbohydrate structures are themselves uniquely synaptic in their localization. Thus, proteins or lipids at the synapse may bear distinct carbohydrates that alter their localization or function. Here, I will review the evidence that there are unique synaptic carbohydrates at the neuromuscular junction. Then, I will review the evidence that such carbohydrates can affect the function of synaptic proteins, with particular attention to agrin, dystroglycan, and the neural cell adhesion molecule (NCAM). Finally, I will review recent data that demonstrates a role for one carbohydrate structure, the cytotoxic T cell (CT) antigen, in neuromuscular development. These studies suggest that glycosylation is an important modification to consider in studies of synapse formation and function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15034276     DOI: 10.1023/B:NEUR.0000020632.41508.83

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  28 in total

1.  Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy.

Authors:  Simon N Fewou; Angie Rupp; Lauren E Nickolay; Kathryn Carrick; Kay N Greenshields; John Pediani; Jaap J Plomp; Hugh J Willison
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

Review 2.  Glycoscience finally comes of age.

Authors:  Anthony H Merry; Catherine L R Merry
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

3.  Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin α2 surrogates.

Authors:  Louis G Chicoine; Louise R Rodino-Klapac; Guohong Shao; Rui Xu; William G Bremer; Marybeth Camboni; Bethannie Golden; Chrystal L Montgomery; Kimberly Shontz; Kristin N Heller; Danielle A Griffin; Sarah Lewis; Brian D Coley; Christopher M Walker; K Reed Clark; Zarife Sahenk; Jerry R Mendell; Paul T Martin
Journal:  Mol Ther       Date:  2013-10-22       Impact factor: 11.454

Review 4.  Extracellular matrix and its receptors in Drosophila neural development.

Authors:  Kendal Broadie; Stefan Baumgartner; Andreas Prokop
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

5.  Functional analysis of glycosylation using Drosophila melanogaster.

Authors:  Shoko Nishihara
Journal:  Glycoconj J       Date:  2019-11-26       Impact factor: 2.916

6.  The alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate receptor trafficking regulator "stargazin" is related to the claudin family of proteins by Its ability to mediate cell-cell adhesion.

Authors:  Maureen G Price; Caleb F Davis; Fang Deng; Daniel L Burgess
Journal:  J Biol Chem       Date:  2005-03-10       Impact factor: 5.157

7.  Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.

Authors:  Katsiaryna Belaya; Sarah Finlayson; Judith Cossins; Wei Wei Liu; Susan Maxwell; Jacqueline Palace; David Beeson
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

8.  Presynaptic secretion of mind-the-gap organizes the synaptic extracellular matrix-integrin interface and postsynaptic environments.

Authors:  Emma Rushton; Jeffrey Rohrbough; Kendal Broadie
Journal:  Dev Dyn       Date:  2009-03       Impact factor: 3.780

9.  The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: Partial dependence on utrophin.

Authors:  Jung Hae Yoon; Kumaran Chandrasekharan; Rui Xu; Matthew Glass; Neha Singhal; Paul T Martin
Journal:  Mol Cell Neurosci       Date:  2009-05-12       Impact factor: 4.314

10.  Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.

Authors:  Rui Xu; Sarah DeVries; Marybeth Camboni; Paul T Martin
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.